Mark Diamond

Mark Diamond

Chairman at DIMERIX LIMITED

Net worth: 264 995 $ as of 2024-03-30

Health Technology
Consumer Services
Distribution Services

Profile

Mark Diamond is currently the Non-Executive Chairman at Dimerix Ltd.
Prior to this, he was the Chief Executive Officer, MD & Executive Director at Percheron Therapeutics Ltd.
from 2010 to 2023.
He also held positions at Alpharma Specialty Pharma LLC, FH Faulding & Co. Ltd., and Faulding Pharmaceuticals Plc.
Mr. Diamond received his undergraduate degree from Monash University and his MBA from Macquarie University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-11 4,893,722 ( 0.54% ) 264 995 $ 2024-03-30

Mark Diamond active positions

CompaniesPositionStart
DIMERIX LIMITED Chairman 2023-01-11
All active positions of Mark Diamond

Former positions of Mark Diamond

CompaniesPositionEnd
PERCHERON THERAPEUTICS LIMITED Chief Executive Officer 2023-05-11
FH Faulding & Co. Ltd. Corporate Officer/Principal -
Faulding Pharmaceuticals Plc Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Mark Diamond's experience

Training of Mark Diamond

Monash University Undergraduate Degree
Macquarie University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Diamond's experience

Connections

24

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PERCHERON THERAPEUTICS LIMITED

Health Technology

DIMERIX LIMITED

Health Technology

Private companies3

Distribution Services

FH Faulding & Co. Ltd.

Health Technology

Faulding Pharmaceuticals Plc

See company connections